Insights

Standalone services Cytovance has recently launched standalone analytical services for GMP and non-GMP testing, presenting a recurring revenue opportunity with biotech and pharma customers that may not require a full production engagement.

Strategic partnerships Recent and ongoing collaborations with Anixa Biosciences, PolyPeptide Group, ExcellGene, and Vectron Biosolutions indicate a strong appetite for integrated development and manufacturing solutions, suggesting cross-sell potential into peptide, large-molecule, and specialized bioservices.

Peptide and large-molecule focus Joint capabilities in microbial and mammalian expression, plus recent peptide development partnerships, position Cytovance to win additional peptide and complex biologics programs across Oklahoma and California, highlighting geography as a selling point.

Clinical-to-commercial adeptness With a track record of cGMP manufacturing for clinical and commercial production and a high batch success rate, Cytovance presents a compelling risk-managed option for sponsors seeking reliable scale-up and transfer of programs.

Leadership and growth signals Strategic leadership hire of a Chief Commercial Officer and growing revenue in the tens-of-millions range, combined with ongoing growth through partnerships, signals readiness for more expansive business development and multi-domain contracts.

Similar companies to Cytovance Biologics

Cytovance Biologics Tech Stack

Cytovance Biologics uses 8 technology products and services including HubSpot Analytics, WordPress, SAP, and more. Explore Cytovance Biologics's tech stack below.

Media & News

Cytovance Biologics's Email Address Formats

Cytovance Biologics uses at least 4 email formats:
Cytovance Biologics Email FormatsExamplePercentage
FLast@cytovance.comJDoe@cytovance.com
91%
Last.First@cytovance.comDoe.John@cytovance.com
5%
LFirst@cytovance.comDJohn@cytovance.com
2%
Last@cytovance.comDoe@cytovance.com
2%

Frequently Asked Questions

What is Cytovance Biologics's phone number?

Minus sign iconPlus sign icon
You can contact Cytovance Biologics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cytovance Biologics's official website and social media links?

Minus sign iconPlus sign icon
Cytovance Biologics's official website is cytovance.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Cytovance Biologics generate?

Minus sign iconPlus sign icon
As of October 2026, Cytovance Biologics's annual revenue is estimated to be $100M - $250M.

What is Cytovance Biologics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Cytovance Biologics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cytovance Biologics have currently?

Minus sign iconPlus sign icon
As of October 2026, Cytovance Biologics has approximately 181 employees across 2 continents, including North America and Asia. Key team members include Chief Commercial Officer (cco): A. S., Chief Financial Officer: S. W. and Vice President Of Quality: B. M. Explore Cytovance Biologics's employee directory with LeadIQ.

What industry does Cytovance Biologics belong to?

Minus sign iconPlus sign icon
Cytovance Biologics operates in the Biotechnology Research industry.

What technology does Cytovance Biologics use?

Minus sign iconPlus sign icon
Cytovance Biologics's tech stack includes HubSpot Analytics, WordPress, SAP, Squarespace Commerce, ADP, Microsoft Active Directory, Pardot and Piwik.

What is Cytovance Biologics's email format?

Minus sign iconPlus sign icon
Cytovance Biologics's email format typically follows the pattern of FLast@cytovance.com. Find more Cytovance Biologics email formats with LeadIQ.

How much funding has Cytovance Biologics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Cytovance Biologics has raised $43M in funding. The last funding round occurred on Nov 28, 2014 for $20M.

When was Cytovance Biologics founded?

Minus sign iconPlus sign icon
Cytovance Biologics was founded in 2003.
Cytovance Biologics logo

Cytovance Biologics

Biotechnology ResearchOklahoma, United States51-200 Employees

Cytovance Biologics is a contract development and manufacturing organization (CDMO) in the biotechnology sector, offering end-to-end biomanufacturing capabilities based on microbial and mammalian expression systems. Its services span from early-stage development, including cell line development and strain selection, to cGMP manufacturing for clinical and commercial production. The company is based in Oklahoma City, Oklahoma, and employs 51 to 200 people. It has formed strategic partnerships to expand capabilities, including a 2025 integration with PolyPeptide Laboratories for peptide development and manufacturing, a 2024 collaboration with ExcellGene SA for mammalian cell line development, and a 2023 partnership with Vectron Biosolutions for customized E. coli strain development. Its product focus encompasses a range of biologics such as biosimilars, cytokines, enzymes and hormones, fusion proteins, bispecifics and monoclonal antibodies, recombinant proteins, vaccines, and related modalities.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2003
Employees
51-200

Section iconFunding & Financials

  • $43M

    Cytovance Biologics has raised a total of $43M of funding over 2 rounds. Their latest funding round was raised on Nov 28, 2014 in the amount of $20M as a Debt Financing.

  • $100M - $250M

    Cytovance Biologics's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.